Cases

Search for a case

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Cases

October 24, 2022

HV Bancorp, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of HV Bancorp, Inc. (“HV Bancorp” or the “Company”)(NASDAQ: HVBC), in connection with the proposed merger of the Company with Citizens Financial Services, Inc. (NASDAQ: CZFS). Under the merger agreement, HV Bancorp shareholders will have the right to elect to receive for each share of HV Bancorp common stock owned, either $30.50 in cash or 0.400 shares of CZFS common stock.

Join Case →

October 21, 2022

Akouos, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akouos, Inc. (“Akouos” or the “Company”) (NASDAQ:AKUS), in connection with the proposed tender offer for the Company by Eli Lilly and Company (NYSE: LLY). Under the tender offer, the Company’s shareholders will receive $12.50 in cash, plus one contingent value right (“CVR”) of up to $3.00 per share for each share of Akouos common stock owned.

Join Case →

October 21, 2022

Archaea Energy Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Archaea Energy Inc. (“Archaea” or the “Company”)(NYSE: LFG) in connection with the proposed acquisition of the Company by BP p.l.c. (NYSE: BP). Under the terms of the merger agreement, the Company’s shareholders will receive $26.00 in cash for each share of Archaea common stock owned.

Join Case →

October 21, 2022

AVEO Pharmaceuticals, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AVEO Pharmaceuticals, Inc. (“AVEO” or the “Company”) (NASDAQ: AVEO), in connection with the proposed acquisition of the Company by LG Chem, Ltd. Under the terms of the merger agreement, the Company’s shareholders will receive $15.00 in cash for each share of AVEO common stock owned. The transaction is valued at approximately $566 million.

Join Case →

October 21, 2022

Continental Resources, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Continental Resources, Inc. (“Continental” or the “Company”) (NYSE: CLR), in connection with the proposed merger of the Company with Omega Acquisition, Inc., via tender offer. Under the terms of the merger agreement, the Company’s shareholders will receive $74.28 in cash for each share of Continental common stock owned.

Join Case →

October 14, 2022

IMARA Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IMARA Inc. (“IMARA” or the “Company”) (NASDAQ: IMRA)in connection with the proposed merger of the Company with Enliven Therapeutics, Inc. (“Enliven”). Under the terms of the merger agreement, IMARA will issue IMARA common stock as merger consideration in exchange for the cancellation of shares of capital stock of Enliven and Enliven will become a wholly owned subsidiary of IMARA.

Join Case →

October 14, 2022

ForgeRock, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ForgeRock, Inc. (“ForgeRock” or the “Company”) (NYSE:FORG), in connection with the proposed acquisition of the Company by Thoma Bravo. Under the terms of the merger agreement, the Company’s shareholders will receive $23.25 in cash for each share of ForgeRock common stock owned.

Join Case →

October 14, 2022

Orthofix Medical Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) in connection with the proposed acquisition of the Company by SeaSpine Holdings Corporation (“SeaSpine”) (NASDAQ: SPNE). Under the terms of the merger agreement, the Company’s shareholders will receive 0.4163 shares of SeaSpine common stock for each Orthofix share owned, representing implied per-share merger consideration of approximately $2.44 based upon SeaSpine’ October 13, 2022 closing price of $5.86.

Join Case →

October 4, 2022

AeroClean Technologies, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AeroClean Technologies, Inc. (“AeroClean” or the “Company”) (NASDAQ: AERC), in connection with the proposed merger of the Company with Molekule, Inc. (“Molekule”). Under the terms of the merger agreement, AeroClean shareholders will own 50.5%, and Molekule shareholders will own 49.5% of the outstanding common equity of the combined company.

Join Case →

We will fight for you and have your back no matter what. Join the tens of thousands of people we’ve helped.

Cases

Search for a case

Cases

HV Bancorp, Inc. Investigation

Akouos, Inc. Investigation

Archaea Energy Inc. Investigation

AVEO Pharmaceuticals, Inc. Investigation

Continental Resources, Inc. Investigation

IMARA Inc. Investigation

ForgeRock, Inc. Investigation

Orthofix Medical Inc. Investigation

AeroClean Technologies, Inc. Investigation

Where to find us?

new york

california

georgia

NEW JERSEY